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TramadolIt has been claimed that, in contrast to most opioids, tramadol does not suppress immune functions. We
therefore, studied the effects of tramadol in comparison to morphine, on the number of phagocytes and the
number of sheep red blood cells (SRBCs) engulfed by each individual cell (phagocytic index) of mouse
peritoneal phagocyte.
In an experimental study, 63 BALB/c mice received morphine, tramadol or saline intraperitoneally. On days 3,
5, and 10, the peritoneal phagocytes were incubated with an equal number of SRBCs. The cells were then
cytocentrifuged onto gelatin-coated slides and examined microscopically.
Ten days after the start of drug administration, the number of phagocytes and the phagocytic index reduced
in morphine group (Pb0.05), and enhanced in tramadol group (Pb0.05).
In conclusion, tramadol stimulation of immune system may offer a good alternative to morphine for the
treatment of patients in whom immunosuppression might be hazardous or in patients who cannot tolerate
the side effects of morphine.© 2009 Published by Elsevier B.V.1. IntroductionOpioids are known to have inhibitory effects on humoral and cellular
immune responses including decreasing lymphoproliferation, natural
killer (NK) activity, macrophage functions, and the production of
interferon-γ and interleukin-2 in the rodent [1–3].
The presence of opioid receptors outside the central nervous system
is increasingly recognized. These receptors have been identiﬁed not only
in peripheral nerves but also in immune inﬂammatory cells [4]. Mu-
opioid receptor expression may be altered under conditions like
inﬂammation [5]. Opiates modulate the immune response by interac-
tion with these receptors [6].
The immunosuppression mediated by opiates may explain the
increased incidence of infection in opioid abusers [3]. Consistent with
these observations, morphine administration has been associated
with increased susceptibility of animals or human to bacterial and
viral infections [7–9], and with decreased survival in tumor-bearing
animals [10,11].
The therapeutic use of morphine might, therefore, be relatively
contraindicated in patients in whom immunosuppression may be
hazardous, especially inpostoperative period, inwhich the functionality
of the immune system is already compromised by stress exposure [12].
Therefore, introduction of an alternative analgesic in these situations
would be essential.+98 381 3334911.
paei).
lsevier B.V.Tramadol is a centrally acting, analgesic drug, with a double
mechanism of action; it binds with low afﬁnity to Mu-opioid receptors,
and activates central monoaminergic pathways inhibiting the neuronal
uptake of serotonin and noradrenaline [13,14].
Several reports address the role of macrophages in morphine-
induced modulation of immunity [15,16]. It has been suggested that, in
contrast to morphine, tramadol does not suppress cellular immune
functions, but it increases the activity of the immune system [17].
Therefore, in this study we aimed to compare the effects of
tramadol with morphine on the phagocytosis of mice peritoneal
phagocytes. The capacity of peritoneal phagocytes to engulf red blood
cells was further investigated.
2. Materials and methods
In an experimental study, 63 six-week-old male BALB/c mice
(Pasteur Institute, Tehran), with an average weight of 20±2 g, were
designated in three groups. Animals were housed at 22±2 ° C, with
light:dark cycle of about 14:10 h and the interventions were blinded in
each stages of experiment for the researcher who carried out the
phagocytic study. First group received 20 mg/kg on day 1, 40 mg/kg on
day 2, and 60mg/kg on day 3, of morphine (Darupakhsh Pharmacy Co.,
Tehran, Iran) intraperitoneally (i.p.) twice a day and 80 mg/kg for
following the seven days. Second group treated with the same doses of
tramadol (Alborz Pharmacy Co., Tehran, Iran) (In a pilot study tramadol
treated mice with equianalgesic doses of morphine underwent seizure,
therefore the same doses of morphine were used for tramadol). The
Table 2







Morphine N4 18 21 12a
2 and 3 43 43 34
1 39 36 54
Tramadol N4 39 28 51b
2 and 3 13 37 20
1 48 35 29
Saline b4 43 40 20c
2 and 3 22 35 71
1 35 25 9
Results are presented as the mean percent phagocytes for groups of 7 mice. ANOVA and
post-hoc Tukey test showed difference between groups; a and c (Pb0.05), b and c
(Pb0.001) and a and b (Pb0.001) just for day ten. The differences for days 3 and 5 were
not signiﬁcant.
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Co., Tehran, Iran) i.p. in volume of 0.5 ml, as scheduled for the ﬁrst two
groups. Sevenmice of each groupwere sacriﬁced by cervical dislocation
on days 3, 5 and 10. The skin of the abdomenwas removed and 5 ml of
tissue culture media (TCM) was injected into peritoneal cavity of each
mouse. After slow massage the peritoneal ﬂuid was collected using a
5 ml syringe. The collected ﬂuid was centrifuged at 1200 rpm for 5 min.
The precipitated cells of each individual mouse were counted under
light microscope and suspended at concentration 2×106 cells per
millimeter in TCM. The collected cells were then incubated with sheep
red blood cells (SRBCs) being opsonized with 10% mouse anti-sheep Ig
as previously reported [18]. The cell suspensions were gently rotated at
1 rpm and 37 °C for 30min. Appropriate aliquots of the cell suspensions
were harvested, and after two washes with ice-cold HBSS (Hank's
Balanced Salt Solution) the cells were cytocentrifuged onto gelatin-
coated slides and microscopically examined for phagocytosis of SRBCs.
The percentage of phagocytes engulfed SRBCs and the number of
erythrocytes ingested per cells (phagocytic index) [19,20], were
statistically analysed by one way ANOVA followed by Tukey test for
multiple comparisons.
3. Results
Animal characteristics were homogeneous in three groups. Three
and ﬁve days following morphine or tramadol administration, the
number of phagocytes (cells with one or more sheep RBC) was not
different compared to control group. However, 10 days after the
beginning of drug administration, the number of phagocytes in 100
peritoneal cells in morphine group (22±8; Pb0.05), and in tramadol
group (49±7; Pb0.05) were signiﬁcantly different in comparison to
control group (32±2), (Table 1).
Experiment was carried out to determine if morphine and
tramadol affected the number of SRBCs ingested per cell (phagocytic
index). Results showed that the percent of phagocytes engulfed 4, 2–3
and 1 RBC on days 3 and 5 in all three groups were not signiﬁcantly
different, but this index for just day 10 was 12%, 34% and 54%,
respectively in morphine treated group (Pb0.001), 51%, 20% and 29%
in tramadol treated group (Pb0.05), compared to control group which
was 20%, 71%, 9%, (Table 2).
4. Discussion
Three and ﬁve days after morphine or tramadol administration, the
number of phagocytes and the number of erythrocytes engulfed by
each individual cell (phagocytic index) were not signiﬁcantly different
compared to saline group. These parameters were reduced in
morphine group and increased in tramadol group, 10 days after the
beginning of drug administration. Furthermore our results showed a
parallel increasing pattern in the number of phagocytes in all three
groups, from days 3 to 10. The mechanism involved in this
phenomenon is not clearly understood. It could be considered as
repeated intra peritoneal injection, which may cause localized
inﬂammation. However, since this phenomenon can be postulated
for all three groups, it might not have any effects on our results.Table 1
The number of phagocytes per 100 peritoneal cells in different groups of mice.
Group Test day
3 5 10
Morphine 11±6 14 ±3 22±8a
Tramadol 20± 4 23±8 49±7b
Saline 18±9 19±11 32±2c
Results are presented as mean phagocytes numbers ±SD for groups of 7 mice.
ANOVA and post-hoc Tukey test showed difference between groups; a and c (pb0.05),
b and c (pb0.05) and a and b (pb0.001) just for day ten. The differences for days 3 and 5
were not signiﬁcant.Additionally, we considered the number of erythrocytes in each cell
(phagocytic index) as phagocytic capacity in each group (the more
SRBCs in each phagocytewas considered as higher phagocytic capacity).
Results showed that the number of phagocyteswith 4 ormore SRBCs on
day 10 in tramadol group was more, and in morphine group was less
than saline group. Thismaymean that sub-acute administration of these
two drugsmight not affect the immune system. However, chronic usage
of morphine may decrease the immune activity but tramadol enhances
it. These results are partly in agreement with the results of Sacerdote et
al. [21]. In this study 2 h after morphine administration no signiﬁcant
modiﬁcation of NK activity was observed, indicating no modiﬁcation of
immune system in acute administration of this drug.
In the present study, morphine and tramadol did not have any
effect on phagocytosis on the third and ﬁfth days of the experiment.
However, on the 10th day, morphine reduced and tramadol enhanced
it. The mechanism in which the effects of these compounds appear
with delay is not clear. A same phenomenon takes place for some
other drugs such as antidepressants. The therapeutic effects of these
drugs appear following one or two weeks of drug administration, but
their pharmacologic activities can be detected soon after drug usage
[22].
It has been shown that tramadol has not had any effect on
phagocytes population or the number of latex particles phagocytized
(phagocytic index) by polymorphnuclear cells and monocytes.
However morphine dose dependently has decreased the monocyte
phagocyting index, following incubationwith the drug [19]. Difference
between the results of the above study and our experiment for
tramadol may be due to differences in drug dose, exposure time,
methods of the studies or species variations.
Although morphine and tramadol share Mu-opioid mechanisms
for their analgesic activities, however, the analgesic effects of tramadol
aremediated also via a separate, non opioidmechanism, caused by the
inhibition of neuronal uptake of noradrenaline and serotonin [[14,17].
These differences may account for the diverse pharmacodynamic
activities of morphine and tramadol on immune functions.
The involvement of the noradrenergic and serotoninergic systems
in neural–immune interactions has been studied by using different
experimental models. Although both enhancement and reduction of
immune responses have been related to the activation of the
noradrenergic system [23], the increase of serotoninergic tone has
usually been associated with stimulation of NK activity and lympho-
cyte proliferation [[21,24]. Consistent with these observations, drugs
which increase serotoninergic tone, such as D-fenﬂuramine and
ﬂuoxetine, stimulate immune function in rodents [24]. Moreover, in
the mouse, the immune effects of tramadol on lymphoproliferation
and NK activity were prevented by the administration of the
nonspeciﬁc serotoninergic antagonist metergoline [21], indicating an
970 H. Shirzad et al. / International Immunopharmacology 9 (2009) 968–970involvement of the serotoninergic system in the immune effects of
this drug. Interestingly, tramadol, when added in vitro to splenocyte
cultures [21], was not able to modulate either proliferation or NK
activity, thus eliminating a direct effect of the drug on immune cells.
Therefore, it can be suggested that activation of the serotoninergic
system might be involved in the immune effects of tramadol.
Compared to most opioids, tramadol has a lower incidence of side
effects such as respiratory depression, nausea, vomiting, constipation,
and sedation. It may beneﬁt patients with history of peptic ulceration,
asthma or opioid dependence and patients whowill require long term
pain treatment [25].
In conclusion, the immune function is differently affected by
morphine and tramadol. Analgesic drugs like tramadol devoid of
immunosuppressive effects or with stimulus activity offer a good
alternative to morphine for the treatment of patients in whom
immunosuppression might be hazardous or in patients who cannot
tolerate the side effects of morphine.
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